click below
click below
Normal Size Small Size show me how
Pain/Heme/Onc 2
with essential knowledge
| Generic | Brand | Category | Indication | Side Effects | US Box Warning | Other Notes |
|---|---|---|---|---|---|---|
| hydrocodone and acetaminophen (PO) (CS-II) | Lortab, Vicodin, Norco | Opioid and nonopioid analgesic combination | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | Opioids risk addiction, misuse, fatal overdose, respiratory depression, accidental-ingestion death, neonatal or abrupt-discontinuation withdrawal, and when combined with benzodiazepines, alcohol, or other CNS depressants, sedation, coma, and death. | US Box Warning: use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase oxycodone concentrations; hepatotoxicity |
| oxycodone and acetaminophen (PO) (CS-II) | Percocet, Endocet | Opioid and nonopioid analgesic combination | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | Opioids risk addiction, misuse, fatal overdose, respiratory depression, accidental-ingestion death, neonatal or abrupt-discontinuation withdrawal, and when combined with benzodiazepines, alcohol, or other CNS depressants, sedation, coma, and death. | US Box Warning: use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase oxycodone concentrations; hepatotoxicity |
| codeine and acetaminophen (PO) (CS-III) | Tylenol with Codeine #3, Tylenol with Codeine #4 | Opioid and nonopioid analgesic combination | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | Opioids risk addiction, misuse, fatal overdose, respiratory depression, accidental-ingestion death, neonatal or abrupt-discontinuation withdrawal, and when combined with benzodiazepines, alcohol, or other CNS depressants, sedation, coma, and death. | USBW: concomitant use/discontinuation of CYP3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors needs careful consideration; respiratory depression&death in children after tonsillectomy/ adenoidectomy who are rapid metabolizers of codeine; hepatotoxicity |
| naloxone (IV, IM, SQ, intranasal) | Narcan Nasal Spray, Zimhi | Opioid antagonist | Opioid overdose | opioid withdrawal syndrome in opioid-dependent populations, pain | ||
| buprenorphine and naloxone (SL) (CS-III) | Suboxone | Partial opioid agonist and opioid antagonist | Opioid use disorder | opioid withdrawal syndrome in opioid-dependent populations, constipation, headache, diaphoresis | potentially life-threatening respiratory depression (when combined with other CNS and respiratory depressants); addition of naloxone to buprenorphine reduces the possibility of parenteral misuse by producing opioid withdrawal symptoms when injected | |
| ferrous sulfate (PO) (OTC) | FeroSul, SlowFe | Iron supplement | Iron deficiency anemia | nausea, stomach upset, constipation (dose-related), dark and tarry stools | accidental overdose of iron is leading cause of fatal poisoning in children under 6 years old | |
| cyanocobalamin (vitamine B12) (PO, IM, SL, intranasal) | --- | Water-soluble vitamin | Vitamin B12 deficiency (manifests as macrocytic anemia) | no major side effects | ||
| folic acid (PO) (OTC) | --- | Water-soluble vitamin | Folic acid deficiency (manifests as macrocytic anemia), prevention of neural tube defects in pregnancy | no major side effects |